Acticor Biotech (XPAR:ALACT) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech ROE % Adjusted to Book Value?

Acticor Biotech's ROE % for the quarter that ended in Jun. 2023 was 0.00%. Acticor Biotech's PB Ratio for the quarter that ended in Jun. 2023 was 176.67. Acticor Biotech's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was 0.00%.

Acticor Biotech ROE % Adjusted to Book Value Historical Data

The historical data trend for Acticor Biotech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech ROE % Adjusted to Book Value Chart

Acticor Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-45.42

Acticor Biotech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial				-	-40.65	-11.31	-	-

Competitive Comparison of Acticor Biotech's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Acticor Biotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acticor Biotech's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acticor Biotech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Acticor Biotech's ROE % Adjusted to Book Value falls into.

Acticor Biotech ROE % Adjusted to Book Value Calculation

Acticor Biotech's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-361.89%	/	N/A
	=	N/A

Acticor Biotech's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	176.67
	=	0.00%

Acticor Biotech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

7V7:Germany

Address

82 Avenue du Maine, Wojo Building, Paris, FRA, 75014

Website

https://www.acticor-biotech.com

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines